UBS Group’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.8K | Buy |
66,785
+60,935
| +1,042% | +$70.1K | ﹤0.01% | 6174 |
|
|
2025
Q1 | $8.72K | Buy |
+5,850
| New | +$8.72K | ﹤0.01% | 7420 |
|
|
2024
Q4 | – | Sell |
-2
| Closed | -$2 | – | 8896 |
|
|
2024
Q3 | $2 | Buy |
+2
| New | +$2 | ﹤0.01% | 8198 |
|
|
2024
Q1 | – | Sell |
-5,708
| Closed | -$8.05K | – | 8430 |
|
|
2023
Q4 | $8.05K | Buy |
5,708
+192
| +3% | +$271 | ﹤0.01% | 6377 |
|
|
2023
Q3 | $6.45K | Buy |
+5,516
| New | +$6.45K | ﹤0.01% | 6161 |
|
|
2023
Q2 | – | Sell |
-2,558
| Closed | -$3.58K | – | 8158 |
|
|
2023
Q1 | $3.58K | Sell |
2,558
-1,007
| -28% | -$1.41K | ﹤0.01% | 7201 |
|
|
2022
Q4 | $4.85K | Sell |
3,565
-1,396
| -28% | -$1.9K | ﹤0.01% | 8071 |
|
|
2022
Q3 | $8K | Buy |
4,961
+374
| +8% | +$603 | ﹤0.01% | 7624 |
|
|
2022
Q2 | $10K | Buy |
4,587
+3,103
| +209% | +$6.77K | ﹤0.01% | 6936 |
|
|
2022
Q1 | $5K | Sell |
1,484
-404
| -21% | -$1.36K | ﹤0.01% | 8082 |
|
|
2021
Q4 | $10K | Buy |
+1,888
| New | +$10K | ﹤0.01% | 7662 |
|